ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,020Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 890

$1.15M Total Retail Price of All Prescriptions

Rank: 31 out of 890

844 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 844 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

19% of this provider’s 844 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 17,819 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,038 655 S3 1 3
FUROSEMIDE 645 564 2 7
MELOXICAM 570 475 3 18
LEVOTHYROXINE SODIUM 567 529 4 2
OMEPRAZOLE 533 444 5 8
AMLODIPINE BESYLATE 489 459 6 1
METFORMIN HCL 420 315 7 6
PRAVASTATIN SODIUM 414 366 8 10
GLIMEPIRIDE 397 320 9 27
LISINOPRIL 377 305 10 4
GABAPENTIN 374 240 11 12
METOPROLOL TARTRATE 360 317 12 15
ZOLPIDEM TARTRATE 351 278 13 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 347 259 14 21
SIMVASTATIN 336 283 15 5
TRAMADOL HCL 333 231 16 16
CARISOPRODOL 274 69 R 17 69
HYDROCHLOROTHIAZIDE 269 239 18 9
METOPROLOL SUCCINATE 268 221 19 17
CITALOPRAM HBR 254 228 20 20
ALLOPURINOL 228 185 21 31
DICLOFENAC SODIUM 223 176 22 96
NEXIUM 210 161 23 14
WARFARIN SODIUM 200 175 24 24
MECLIZINE HCL 185 165 25 97
ATORVASTATIN CALCIUM 182 149 26 13
ISOSORBIDE MONONITRATE ER 174 140 27 60
POTASSIUM CHLORIDE 172 157 28 11
AZITHROMYCIN 168 120 29 37
PANTOPRAZOLE SODIUM 168 148 29 34
NAMENDA 165 165 31 36
CARVEDILOL 159 146 32 22
CLOPIDOGREL 157 134 33 28
LOVASTATIN 150 122 34 46
CRESTOR 141 105 35 25
AMLODIPINE BESYLATE-BENAZEPRIL 140 136 36 41
TAMSULOSIN HCL 134 128 37 32
ATENOLOL 130 126 38 23
ADVAIR DISKUS 125 91 39 52
TRIAMTERENE-HCTZ 124 124 40 61
ALENDRONATE SODIUM 121 116 41 38
MEGESTROL ACETATE 116 116 R 42 92
DONEPEZIL HCL 116 116 42 30
AMITRIPTYLINE HCL 112 86 R 44 43
ESCITALOPRAM OXALATE 112 97 44 51
CYMBALTA 105 49 46 45
SYNTHROID 105 94 46 53
DIOVAN HCT 105 81 46 48
PAROXETINE HCL 103 81 49 68
VENLAFAXINE HCL ER 101 82 50 114
ETODOLAC 100 79 51 197
TRAMADOL HCL-ACETAMINOPHEN 96 96 52 117
CIPROFLOXACIN HCL 96 83 52 58
TRAZODONE HCL 94 77 54 40
ESTRADIOL 94 53 R 54 118
SERTRALINE HCL 91 68 56 26
PLAVIX 90 80 57 42
LYRICA 88 66 58 71
CLONIDINE HCL 87 77 59 35
EXELON 86 86 60 113
DIOVAN 85 77 61 33
DILTIAZEM ER 84 69 62 129
CYCLOBENZAPRINE HCL 82 73 R 63 64
ROPINIROLE HCL 81 41 64 93
QUETIAPINE FUMARATE 81 72 64 73
NAPROXEN 81 74 64 84
DOXYCYCLINE HYCLATE 80 69 67 89
CELEBREX 79 66 68 91
ACTOS 79 72 68 88
DIGOXIN 77 77 70 65
OXYBUTYNIN CHLORIDE ER 75 66 71 154
FENTANYL 73 48 S2 72 151
DICYCLOMINE HCL 72 53 73 295
AVODART 72 72 73 198
RAMIPRIL 71 64 75 80
PREDNISONE 71 60 75 47
SPIRIVA 70 45 77 66
GLYBURIDE-METFORMIN HCL 68 59 R 78 115
SANTYL 67 62 79 246
PROAIR HFA 67 55 79 55
RANITIDINE HCL 66 66 81 49
NIFEDIPINE ER 66 61 81 75
JANUVIA 66 44 81 59
BENAZEPRIL HCL 66 50 81 44
DOXAZOSIN MESYLATE 65 53 85 70
AGGRENOX 65 59 85 219
ALBUTEROL SULFATE 64 37 87 162
TIZANIDINE HCL 64 14 87 106
CEPHALEXIN 63 53 89 119
EVISTA 63 63 89 182
PRAMIPEXOLE DIHYDROCHLORIDE 61 60 91 175
DILTIAZEM 24HR CD 61 61 91 156
OXYCODONE HCL-ACETAMINOPHEN 60 37 S2 93 127
PROMETHAZINE HCL 60 31 R 93 104
LOSARTAN-HYDROCHLOROTHIAZIDE 60 60 93 57
PHENYTOIN SODIUM EXTENDED 59 30 96 111
MIRTAZAPINE 59 34 96 82
FLUOXETINE HCL 55 53 98 63
OXYCODONE HCL 55 0 S2 98 123
HYDROXYZINE PAMOATE 53 0 R 100 205
POLYETHYLENE GLYCOL 3350 53 45 100 67
NABUMETONE 52 48 102 143
MUPIROCIN 51 50 103 121
BISOPROLOL-HYDROCHLOROTHIAZIDE 51 51 103 122
LEVOFLOXACIN 51 44 103 107
QUINAPRIL HCL 51 48 103 116
SUCRALFATE 51 40 103 158
AMOX TR-POTASSIUM CLAVULANATE 50 36 108 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 27, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.